text stringlengths 81 4.38k |
|---|
<s>[INST] Provide the recruitment status for trial id: NCT04906330 [/INST] Recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT04906330 [/INST] Breast Cancer </s> |
<s>Trial Id: Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT Recruitment Status: Completed Trail description: The purpose of this study is to elucidate the value of dual-time-point PET/CT in the recurrence of breast cancer and to determine whether the method is better than the modalities used in the standar... |
<s>[INST] Provide inclusion criteria for trial id: NCT01552655 [/INST] Clinical suspected recurrence of breast cancer
Blood glucose level less than 8,0 mmol/L </s> |
<s>[INST] Provide exclusion criteria for trial id: NCT01552655 [/INST] Disqualified patients
Other malignancies
< 18 years
< 50 kg
> 90 kg
Pregnant or lactating
Patients with permanent address outside of the Region of Southern Denmark
Estimated inability to collaborate </s> |
<s>[INST] Provide description for trial id: NCT01552655 [/INST] The purpose of this study is to elucidate the value of dual-time-point PET/CT in the recurrence of breast cancer and to determine whether the method is better than the modalities used in the standard work up.
150 patients with suspected breast cancer rec... |
<s>[INST] Provide title for trial id: NCT01552655 [/INST] Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT </s> |
<s>[INST] Provide the recruitment status for trial id: NCT01552655 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT01552655 [/INST] Breast Cancer Recurrent </s> |
<s>Trial Id: PERSONAL - Sleep In Breast Cancer Recruitment Status: Completed Trail description: Sleep is essential for human function, immunity, and well-being. In the general population, sleep disturbance and insomnia cause significant health problems and impact on the quality of life of many individuals. The incidenc... |
<s>[INST] Provide inclusion criteria for trial id: NCT05093426 [/INST] None </s> |
<s>[INST] Provide exclusion criteria for trial id: NCT05093426 [/INST] None </s> |
<s>[INST] Provide description for trial id: NCT05093426 [/INST] Sleep is essential for human function, immunity, and well-being. In the general population, sleep disturbance and insomnia cause significant health problems and impact on the quality of life of many individuals. The incidence of insomnia in cancer patient... |
<s>[INST] Provide title for trial id: NCT05093426 [/INST] PERSONAL - Sleep In Breast Cancer </s> |
<s>[INST] Provide the recruitment status for trial id: NCT05093426 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT05093426 [/INST] Insomnia, Breast Cancer </s> |
<s>Trial Id: Identification of New Prognostic Markers for Breast Cancer. Recruitment Status: Recruiting Trail description: Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The sam... |
<s>[INST] Provide inclusion criteria for trial id: NCT03436069 [/INST] Adult female patients with breast cancer </s> |
<s>[INST] Provide exclusion criteria for trial id: NCT03436069 [/INST] Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix.
Subject under guardianship or subject deprived of liberty
Impossibility of collecting information on exposure (subjects recently arrived in France, fo... |
<s>[INST] Provide description for trial id: NCT03436069 [/INST] Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same approach had already been used and validated in lung tum... |
<s>[INST] Provide title for trial id: NCT03436069 [/INST] Identification of New Prognostic Markers for Breast Cancer. </s> |
<s>[INST] Provide the recruitment status for trial id: NCT03436069 [/INST] Recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT03436069 [/INST] Breast Cancer </s> |
<s>Trial Id: Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer Recruitment Status: Unknown status Trail description: In this study we aim to:
Assess serum miRNA-373, miRNA-425-5p expression in patients with breast cancer.
Explore their correlations with breast cancer clinicopathological documented data i... |
<s>[INST] Provide inclusion criteria for trial id: NCT04720508 [/INST] Female age 20 years or older
documented diagnosis of breast cancer based on physical examination, imaging and histopathology
possibility of obtaining blood samples from the subject. </s> |
<s>[INST] Provide exclusion criteria for trial id: NCT04720508 [/INST] All patients with prior history of exposure to chemotherapy, radiotherapy or hormonal therapy .
patients with other malignancies.
patients with chronic inflammatory diseases.
patients with missed documentation for histopathological diagnosis of bre... |
<s>[INST] Provide description for trial id: NCT04720508 [/INST] In this study we aim to:
Assess serum miRNA-373, miRNA-425-5p expression in patients with breast cancer.
Explore their correlations with breast cancer clinicopathological documented data including staging, grading and tumor receptors. </s> |
<s>[INST] Provide title for trial id: NCT04720508 [/INST] Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer </s> |
<s>[INST] Provide the recruitment status for trial id: NCT04720508 [/INST] Unknown status </s> |
<s>[INST] Provide the medical condition for trial id: NCT04720508 [/INST] Breast Cancer </s> |
<s>Trial Id: What Matters Most: Choosing the Right Breast Cancer Surgery for You Recruitment Status: Completed Trail description: What Matters Most is a study that aims to determine how best to help women of lower socioeconomic status make high-quality decisions about early stage breast cancer treatments. What Matters ... |
<s>[INST] Provide inclusion criteria for trial id: NCT03136367 [/INST] Assigned female at birth;
18 years and older;
Confirmed diagnosis (via biopsy) of early stage breast cancer (stages I-IIIA);
Eligible for both breast-conserving surgery and mastectomy based on medical records and clinician's opinion before surgery;... |
<s>[INST] Provide exclusion criteria for trial id: NCT03136367 [/INST] Transgender men and women;
Women who have undergone prophylactic mastectomy;
Women with visual impairment;
Women with a diagnosis of severe mental illness or severe dementia;
Women with inflammatory breast carcinoma. </s> |
<s>[INST] Provide description for trial id: NCT03136367 [/INST] What Matters Most is a study that aims to determine how best to help women of lower socioeconomic status make high-quality decisions about early stage breast cancer treatments. What Matters Most will be comparing two decision aids used in the clinic visit... |
<s>[INST] Provide title for trial id: NCT03136367 [/INST] What Matters Most: Choosing the Right Breast Cancer Surgery for You </s> |
<s>[INST] Provide the recruitment status for trial id: NCT03136367 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT03136367 [/INST] Breast Cancer </s> |
<s>Trial Id: Comparison of Ultrasound and Breast MRI for Breast Cancer Detection Recruitment Status: Recruiting Trail description: The goal of this randomized clinical trial is to compare diagnostic results of secondary breast cancer surveillance using breast ultrasound abbreviated MRI and full protocol MRI. Inclusion ... |
<s>[INST] Provide inclusion criteria for trial id: NCT05797545 [/INST] Women aged 20-75 with a history of breast cancer (in situ carcinoma or invasive breast cancer [stage 0-3])
Women with a negative resection margin in the pathology results of the last surgical specimen from past breast cancer
Women with dense breast... |
<s>[INST] Provide exclusion criteria for trial id: NCT05797545 [/INST] Patients with symptoms related to current breast cancer or breast cancer recurrence (palpable mass, bloody or transparent nipple secretion, palpable mass in the axillary region, abnormal skin changes in the breast or nipple)
If you have been diagno... |
<s>[INST] Provide description for trial id: NCT05797545 [/INST] The goal of this randomized clinical trial is to compare diagnostic results of secondary breast cancer surveillance using breast ultrasound abbreviated MRI and full protocol MRI. </s> |
<s>[INST] Provide title for trial id: NCT05797545 [/INST] Comparison of Ultrasound and Breast MRI for Breast Cancer Detection </s> |
<s>[INST] Provide the recruitment status for trial id: NCT05797545 [/INST] Recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT05797545 [/INST] Breast Neoplasms, Breast Cancer </s> |
<s>Trial Id: The Effect of Breast Cancer Screening Training Recruitment Status: Active, not recruiting Trail description: The lack of knowledge of women on breast cancer and health literacy poses a major obstacle to people's breast cancer screening behaviors and beliefs. In order to increase social sensitivity and awar... |
<s>[INST] Provide inclusion criteria for trial id: NCT05723237 [/INST] Women aged 18 and over,
Volunteering to participate in the study,
Working in the municipality for at least 1 month and
Not having any communication problems </s> |
<s>[INST] Provide exclusion criteria for trial id: NCT05723237 [/INST] Women who have any communication barrier and
Do not volunteer to participate in the study will be excluded from the study. </s> |
<s>[INST] Provide description for trial id: NCT05723237 [/INST] The lack of knowledge of women on breast cancer and health literacy poses a major obstacle to people's breast cancer screening behaviors and beliefs. In order to increase social sensitivity and awareness on this issue; In particular, it is important to re... |
<s>[INST] Provide title for trial id: NCT05723237 [/INST] The Effect of Breast Cancer Screening Training </s> |
<s>[INST] Provide the recruitment status for trial id: NCT05723237 [/INST] Active, not recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT05723237 [/INST] Women's Health: Neoplasm of Breast </s> |
<s>Trial Id: Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy Recruitment Status: Completed Trail description: The aim of this trial is to investigate the effectiveness of acupuncture on quality of life in patients with breast cancer receiving chemother... |
<s>[INST] Provide inclusion criteria for trial id: NCT01727362 [/INST] diagnosed breast cancer (invasive, intraductal, hormone-sensitive and not hormone-sensitive, only locoregional metastases)
current chemotherapy at Mammazentrum Hamburg with regimen FEC/DOC or EC/DOC
willingness to receive acupuncture within the nex... |
<s>[INST] Provide exclusion criteria for trial id: NCT01727362 [/INST] distant metastases
blood coagulation disorder and/or current use of anticoagulants
serious acute or chronic mental or physical disorders
clinically relevant cardiac arrhythmia symptoms
insufficient German language ability </s> |
<s>[INST] Provide description for trial id: NCT01727362 [/INST] The aim of this trial is to investigate the effectiveness of acupuncture on quality of life in patients with breast cancer receiving chemotherapy compared to routine care. </s> |
<s>[INST] Provide title for trial id: NCT01727362 [/INST] Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy </s> |
<s>[INST] Provide the recruitment status for trial id: NCT01727362 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT01727362 [/INST] Breast Cancer </s> |
<s>Trial Id: Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer. Recruitment Status: Unknown status Trail description: Three-dimensional functional Metabolic Imaging (3D MIRA) is a new infrared imaging technology using the Real Imager 4(RI4) developed by Re... |
<s>[INST] Provide inclusion criteria for trial id: NCT02009150 [/INST] Female
Woman has read, understood and signed the inform consent form
Age: 20 years and older
Women who are asymptomatic for breast cancer
Proven carriers of deleterious BRCA1 or BRCA2 mutations Or Women that were found to have a lifetime risk of de... |
<s>[INST] Provide exclusion criteria for trial id: NCT02009150 [/INST] Women who have had a mammography and/or ultrasound examination performed on the day of the study prior to MIRA scan
Women who had a lumpectomy surgery
Women who had undergone mastectomy and/or reconstruction
Women who have undergone any type of bre... |
<s>[INST] Provide description for trial id: NCT02009150 [/INST] Three-dimensional functional Metabolic Imaging (3D MIRA) is a new infrared imaging technology using the Real Imager 4(RI4) developed by Real Imaging. This technology generates 3D metabolic maps and based on sophisticated machine learning technology, provi... |
<s>[INST] Provide title for trial id: NCT02009150 [/INST] Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer. </s> |
<s>[INST] Provide the recruitment status for trial id: NCT02009150 [/INST] Unknown status </s> |
<s>[INST] Provide the medical condition for trial id: NCT02009150 [/INST] Breast Cancer </s> |
<s>Trial Id: Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer Recruitment Status: Recruiting Trail description: Breast cancer patients who undergo neoadjuvant systemic therapy and have residual breast cancer identified at the time of surgery exhibit a high (>50%) risk of future life-threat... |
<s>[INST] Provide inclusion criteria for trial id: NCT04703244 [/INST] Age ≥18 years.
Diagnosis of invasive breast cancer treated with neoadjuvant systemic therapy.
Surgically resectable disease following neoadjuvant systemic treatment.
At least one of the following must be true:
Received at least 2 weeks of neoadju... |
<s>[INST] Provide exclusion criteria for trial id: NCT04703244 [/INST] Ineligible for surgery.
History of prior malignancy <3 years prior to registration. Exceptions for non-melanoma skin cancer, papillary thyroid cancer, non-invasive cancer (e.g., carcinoma in situ of the cervix). </s> |
<s>[INST] Provide description for trial id: NCT04703244 [/INST] Breast cancer patients who undergo neoadjuvant systemic therapy and have residual breast cancer identified at the time of surgery exhibit a high (>50%) risk of future life-threatening recurrences and death. </s> |
<s>[INST] Provide title for trial id: NCT04703244 [/INST] Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer </s> |
<s>[INST] Provide the recruitment status for trial id: NCT04703244 [/INST] Recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT04703244 [/INST] Breast Cancer, Residual </s> |
<s>Trial Id: Breast Cancer Risk Reduction: A Patient Doctor Intervention Recruitment Status: Completed Trail description: The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for wo... |
<s>[INST] Provide inclusion criteria for trial id: NCT01830933 [/INST] Patient component:
Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
Between the ages of 40 and 74
Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or Wh... |
<s>[INST] Provide exclusion criteria for trial id: NCT01830933 [/INST] Patient component: Women whose physicians object to their participation in the study
Physician component: No exclusion criteria for physicians </s> |
<s>[INST] Provide description for trial id: NCT01830933 [/INST] The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, an... |
<s>[INST] Provide title for trial id: NCT01830933 [/INST] Breast Cancer Risk Reduction: A Patient Doctor Intervention </s> |
<s>[INST] Provide the recruitment status for trial id: NCT01830933 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT01830933 [/INST] Breast Cancer </s> |
<s>Trial Id: VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer Recruitment Status: Completed Trail description: The purpose of this study is to determine the uptake, (semi-)quantification and localization of the VEGF targeting fluorescent tracer bevacizumab-IDRye800CW in breast cancer tissue, surrounding health... |
<s>[INST] Provide inclusion criteria for trial id: NCT01508572 [/INST] Age ≥ 18 years.
Patients with proven breast cancer (cytology, histology) who are scheduled to receive operation intervention.
Tumor size of at least 15 mm diameter according to anatomical imaging data.
Signed written informed consent.
Able to compl... |
<s>[INST] Provide exclusion criteria for trial id: NCT01508572 [/INST] Other invasive malignancy.
Serious other medical conditions.
Pregnant or lactating women. (Documentation of a negative pregnancy test must be available for pre-menopausal women with intact reproductive organs and for women less than two years after... |
<s>[INST] Provide description for trial id: NCT01508572 [/INST] The purpose of this study is to determine the uptake, (semi-)quantification and localization of the VEGF targeting fluorescent tracer bevacizumab-IDRye800CW in breast cancer tissue, surrounding healthy tissue, tumor margins and lymph nodes. This is measur... |
<s>[INST] Provide title for trial id: NCT01508572 [/INST] VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer </s> |
<s>[INST] Provide the recruitment status for trial id: NCT01508572 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT01508572 [/INST] Breast Cancer </s> |
<s>Trial Id: Cyberknife for Early Stage Breast Cancer Recruitment Status: Completed Trail description: This phase II study based on the Cyberknife Society study will evaluate the technical feasibility and acute toxicity of Partial Breast Irradiation (PBI) with the Cyberknife. It will evaluate quality of life (QOL) issu... |
<s>[INST] Provide inclusion criteria for trial id: NCT03946683 [/INST] Patients with stage 0, I, or II (Tis, Ti, or T2 <=3cm & NO) histologically confirmed invasive non-lobular carcinoma or ductal carcinoma in situ of the breast with a lesion <= 3 cm, treated with wide excision.
Negative inked histologic margins of ex... |
<s>[INST] Provide exclusion criteria for trial id: NCT03946683 [/INST] Patients with invasive lobular carcinoma or nonepithelial breast malignancies such as sarcoma or lymphoma.
Patients with multicentric carcinoma or with other clinically or radiographically suspicious areas in the ipsilateral breast unless confirmed... |
<s>[INST] Provide description for trial id: NCT03946683 [/INST] This phase II study based on the Cyberknife Society study will evaluate the technical feasibility and acute toxicity of Partial Breast Irradiation (PBI) with the Cyberknife. It will evaluate quality of life (QOL) issues as they relate to treatment-related... |
<s>[INST] Provide title for trial id: NCT03946683 [/INST] Cyberknife for Early Stage Breast Cancer </s> |
<s>[INST] Provide the recruitment status for trial id: NCT03946683 [/INST] Completed </s> |
<s>[INST] Provide the medical condition for trial id: NCT03946683 [/INST] Early Stage Breast Cancer </s> |
<s>Trial Id: Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning Recruitment Status: Recruiting Trail description: RadioVal will develop and implement interoperable solutions for clinical deployment of the radiomics tools, including information, training, and commun... |
<s>[INST] Provide inclusion criteria for trial id: NCT05070884 [/INST] Females ≥ 18 years up to 85 years old
Individuals referred to hospitals for diagnosis of breast cancer
Availability of radiological images: 2D mammography or 2D synthetic digital tomosynthesis, ultrasound, or magnetic resonance
Availability of path... |
<s>[INST] Provide exclusion criteria for trial id: NCT05070884 [/INST] Patient with incomplete or low-quality data (radiological, pathological or clinical) </s> |
<s>[INST] Provide description for trial id: NCT05070884 [/INST] RadioVal will develop and implement interoperable solutions for clinical deployment of the radiomics tools, including information, training, and communication packages for clinicians and patients, as well as standard operating procedures for the integrati... |
<s>[INST] Provide title for trial id: NCT05070884 [/INST] Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning </s> |
<s>[INST] Provide the recruitment status for trial id: NCT05070884 [/INST] Recruiting </s> |
<s>[INST] Provide the medical condition for trial id: NCT05070884 [/INST] Breast Cancer </s> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.